JP2017519801A5 - - Google Patents

Download PDF

Info

Publication number
JP2017519801A5
JP2017519801A5 JP2017500885A JP2017500885A JP2017519801A5 JP 2017519801 A5 JP2017519801 A5 JP 2017519801A5 JP 2017500885 A JP2017500885 A JP 2017500885A JP 2017500885 A JP2017500885 A JP 2017500885A JP 2017519801 A5 JP2017519801 A5 JP 2017519801A5
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl
compound
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017500885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/065870 external-priority patent/WO2016005577A1/en
Publication of JP2017519801A publication Critical patent/JP2017519801A/ja
Publication of JP2017519801A5 publication Critical patent/JP2017519801A5/ja
Withdrawn legal-status Critical Current

Links

JP2017500885A 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用 Withdrawn JP2017519801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14176737 2014-07-11
EP14176737.6 2014-07-11
PCT/EP2015/065870 WO2016005577A1 (en) 2014-07-11 2015-07-10 Use of anthelmintic agents against dirofilaria immitis

Publications (2)

Publication Number Publication Date
JP2017519801A JP2017519801A (ja) 2017-07-20
JP2017519801A5 true JP2017519801A5 (enExample) 2018-07-26

Family

ID=51167759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500885A Withdrawn JP2017519801A (ja) 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用

Country Status (7)

Country Link
US (1) US20170196854A1 (enExample)
EP (1) EP3166605A1 (enExample)
JP (1) JP2017519801A (enExample)
CN (1) CN106470683A (enExample)
AU (1) AU2015286635A1 (enExample)
BR (1) BR112017000520A2 (enExample)
WO (1) WO2016005577A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3448859T (lt) 2017-03-20 2019-10-25 Forma Therapeutics Inc Pirolpirolo kompozicijos, kaip piruvato kinazės (pkr) aktyvatoriai
JOP20190223A1 (ar) 2017-04-01 2019-09-26 Novartis Ag عملية لتحضير حمض 1-(4- ميثان سلفونيل -2- تراي فلورو ميثيل - بنزيل)-2- ميثيل -1h- بيرولو [2، 3-b] بيريدين -3- يل- أسيتيك
US10675274B2 (en) 2018-09-19 2020-06-09 Forma Therapeutics, Inc. Activating pyruvate kinase R
ES2989438T3 (es) 2018-09-19 2024-11-26 Novo Nordisk Healthcare Ag Activación de la piruvato cinasa R
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
BR112021024726A2 (pt) * 2019-06-07 2022-01-18 Elanco Tiergesundheit Ag Novos derivados bicíclicos
HUE072832T2 (hu) 2019-09-19 2025-12-28 Novo Nordisk Healthcare Ag Piruvát kináz R-t (PKR) aktiváló készítmények
WO2021174069A1 (en) * 2020-02-28 2021-09-02 Auburn University Dirofilaria volatile organic compound signatures and uses thereof
EP4116305A4 (en) 2020-03-06 2024-07-17 Guangzhou Maxinovel Pharmaceuticals Co., Ltd. THIENOPYRIMIDINE DERIVATIVE AND PREPARATION METHOD THEREFOR
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201041868A (en) * 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) * 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use
EP2468096A1 (en) * 2010-12-21 2012-06-27 Intervet International BV Anthelmintic combinations
PL2922845T3 (pl) * 2012-11-20 2018-11-30 Merial, Inc. Związki przeciwrobacze oraz ich kompozycje i sposób stosowania

Similar Documents

Publication Publication Date Title
JP2017519801A5 (enExample)
JP2017519802A5 (enExample)
JP2016536364A5 (enExample)
JP2015535277A5 (enExample)
JP2016536363A5 (enExample)
AR076258A1 (es) Agentes antihelminticos y su utilizacion
JP2013530176A5 (enExample)
JP2015522650A5 (enExample)
JP2016540742A5 (enExample)
EA201590023A1 (ru) Новые 4-замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные бензимидазолами, в качестве противовирусных средств против респираторного синцитиального вируса
AR056327A1 (es) Compuestos de nucleosidos para el tratamiento de infecciones virales
MX2017010735A (es) Inhibidores de inhibidores del factor beta de crecimiento de transformacion (tgf-beta).
JP2014520767A5 (enExample)
AR085585A1 (es) Vinil- y alquinilciclohexanoles sustituidos como principios activos contra estres abiotico de plantas
JP2014502988A5 (enExample)
JP2016501185A5 (enExample)
PE20160540A1 (es) Inhibidores de bromodominios
RU2013144215A (ru) Средство для борьбы с эндопаразитами
RU2015121431A (ru) Замещенные производные индол-5-ола и их терапевтическое применение
MX389142B (es) Compuestos espiro triciclicos.
JP2016503797A5 (enExample)
ATE540037T1 (de) Triazolopyridine als phosphodiesterasehemmer zur behandlung von hautkrankheiten
EA201990902A1 (ru) Ингибиторы тирозинкиназы брутона
IN2014DN07283A (enExample)
AR093937A1 (es) Compuestos quimicos